---
title: "Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reaches Key Midpoint Milestone in Multiple Sclerosis Imaging Study"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291174602.md"
description: "Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reaches Key Midpoint Milestone in Multiple Sclerosis Imaging Study"
datetime: "2026-06-29T17:00:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291174602.md)
  - [en](https://longbridge.com/en/news/291174602.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291174602.md)
generator: "portal-rs"
---

# Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reaches Key Midpoint Milestone in Multiple Sclerosis Imaging Study


### Related Stocks

- [QNTM.US](https://longbridge.com/en/quote/QNTM.US.md)

## Related News & Research

- [Quantum BioPharma (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments](https://longbridge.com/en/news/299931009.md)
- [Quantum BioPharma Highlights Year of Financing Moves, Debt Settlement and Governance Changes](https://longbridge.com/en/news/299358337.md)
- [Quantum BioPharma Gains Rodman & Renshaw BUY Rating and US$8 Target](https://longbridge.com/en/news/299320922.md)
- [Quantum BioPharma Showcases FDA-Backed Lucid-MS Program at Toronto Growth Summit](https://longbridge.com/en/news/299051115.md)
- [Quantum BioPharma board authorizes Class A multiple-voting share offering to lift control stake to 75.27%](https://longbridge.com/en/news/299357088.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**